Publications by authors named "T Kishida"
Background: Lower limb peripheral artery disease classified as Rutherford category IV, is characterized by lower limb ischemic pain both during exertion and at rest. This disease has an unclear course. We aimed to evaluate outcome predictors in this patient group after endovascular therapy.
View Article and Find Full Text PDFBackground: Lymph node (LN) metastasis is a poor prognostic factor in patients with prostate cancer. Elucidating the mechanisms underlying cancer progression in the metastatic microenvironment of LNs is crucial to establishing novel therapies. Adipocytes interact with cancer cells and regulate cancer progression.
View Article and Find Full Text PDFArticle Synopsis
- The study examines the effectiveness of performing "upfront neck dissection" (ND) before chemoradiation therapy (CRT) in patients with locally advanced squamous cell carcinoma of the head and neck.
- A total of 121 patients were assessed, with 35 undergoing upfront ND, leading to significantly better 2-year locoregional recurrence-free survival rates (93.7%) compared to those who did not undergo the procedure (71.0%).
- The results suggest that upfront ND could improve local control of the disease and reduce the need for subsequent salvage surgeries, enhancing overall patient outcomes.
Article Synopsis
- Nivolumab, an immunotherapy drug, can cause immune-related adverse events (irAEs) affecting various organs, though renal complications are less common and can be challenging to diagnose.
- A case study of a 65-year-old man with hypopharyngeal carcinoma revealed renal dysfunction and pyuria after nivolumab treatment, which initially led to confusion regarding the diagnosis of a renal irAE due to only mild creatinine elevation.
- The study emphasizes the importance of considering renal irAEs in patients with abnormal urinalysis and renal dysfunction, as missed diagnoses can occur when renal biopsies are not performed.
Objective: To evaluate comorbidities in Japanese testicular cancer (TC) survivors in a multi-institutional, cross-sectional study.
Methods: This study enrolled TC survivors who visited any of the eight high-volume institutions in Japan from 2018 to 2019. After obtaining informed consent, participants answered questionnaires about their comorbidities.